These novel therapies, including Semaglutide , Tirzepatide , and Retatrutide , represent a significant advancement in addressing type 2 hyperglycemia and promoting weight loss . They operate by emulating the body’s natural hormone substance, enabling to moderate blood sugar and decrease cravings.